Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Zitelli, B. J.
Right arrow Articles by Maroon, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zitelli, B. J.
Right arrow Articles by Maroon, T. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CARBAMAZEPINE
*DIGOXIN
*ERYTHROMYCIN
*THEOPHYLLINE
*WARFARIN
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Erythromycin-induced Drug Interactions

An Illustrative Case and Review of the Literature

Basil J. Zitelli

Schools of Medicine and Pharmacy, University of Pittsburgh, and Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania

Denise L. Howrie

Schools of Medicine and Pharmacy, University of Pittsburgh, and Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania

Harold Altman

Schools of Medicine and Pharmacy, University of Pittsburgh, and Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania

Thomas J. Maroon

Schools of Medicine and Pharmacy, University of Pittsburgh, and Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania

The authors report a case of erythromycin-induced carbamazepine toxicity in a 6-year-old child following use of erythromycin ethylsuccinate (50 mg/kg/day). Within 5 days of erythromycin use, vomiting, weakness, lethargy, ataxia, nystagmus, and cogwheeling movements developed. A serum carbamazepine concentration had increased from 11.9 mg/L (measured 1 week prior to antibiotic use) to 25.8 mg/L. Following erythromycin withdrawal, serum concentrations returned toward baseline, and symptoms resolved.

Erythromycin has known effects on hepatic enzyme function, with altered cytochrome P-450 function. The dramatic reduction in carbamazepine clearance observed in this patient is similar to that reported when erythromycin is used concurrently with other drugs. A brief review of potentially significant erythromycin drug interactions is presented.

Clinical Pediatrics, Vol. 26, No. 3, 117-119 (1987)
DOI: 10.1177/000992288702600302
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 JPEN J Parenter Enteral NutrHome page
R. N. Dickerson, J. N. Mitchell, L. M. Morgan, G. O. Maish III, M. A. Croce, G. Minard, and R. O. Brown
Disparate Response to Metoclopramide Therapy for Gastric Feeding Intolerance in Trauma Patients With and Without Traumatic Brain Injury
JPEN J Parenter Enteral Nutr, November 1, 2009; 33(6): 646 - 655.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
C. E. Stafstrom, V. Nohria, H. Loganbill, R. Nahouraii, R.-M. Boustany, and G. R. DeLong
Erythromycin-Induced Carbamazepine Toxicity: A Continuing Problem
Arch Pediatr Adolesc Med, January 1, 1995; 149(1): 99 - 101.
[Abstract] [PDF]